References in periodicals archive ?
The Complaint alleges that during the Class Period, defendants manipulated the Company's sales by increasing the inventory of its distributors, thereby artificially inflating ICN's earnings and stock price.
The Complaint alleges that NeoPharm and certain of its directors and officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 promulgated thereunder, by issuing a series of material misrepresentations to the market during the Class Period, thereby artificially inflating the price of NeoPharm common stock Hospital Bonds.
Plaintiff alleges that during the period of April 25, 2001 to December 21, 2001 inclusive (the "Class Period") Defendants issued a series of material misrepresentations to the market in press releases and SEC filings thereby artificially inflating the price of Homestore securities.
The complaint alleges that the foregoing misstatements and omissions of material facts in violation of the federal securities laws had the effect of artificially inflating Global Crossing's share price.
Our complaint alleges that Art Technology, and certain of its officers and directors, violated federal securities laws by issuing materially false and misleading statements during the Class Period that had the effect of artificially inflating the market price of the Company's securities.
The complaint charges that defendants violated Sections 10 (b) and 20 (a) of the Securities and Exchange Act of 1934, and Rule 10b-5 promulgated thereunder, by issuing a series of materially false and misleading statements to the market during the class period concerning its supposedly strong and growing sales thereby artificially inflating the value of the Company's stock price.